SUMMARYA derivative of tetraknazine ("BZ, 1) containing an iodovinyl group (I-TBZ, was prepared as a potential radiotracer for the vesicular monoamine transporter. The synthesis of h was achieved by ethynylation of TBZ. The ethynyl derivative 4, was converted to the corresponding vinylstannane z. [W'JI-TBZ can readily cross the blood brain barrier and localize in the brain (0.92 and 0.36 % dose/organ, at 2 min and 30 min, respectively). However, no specific regional uptake of the ligand was observed. Subsequent biodistribution studies performed using two well resolved peaks obtained from chiral HPLC separation of a, demonstrated that Fraction I displayed higher brain uptake (0.6 % dose/organ. 20 min) than the latter peak (Fraction 11, 0.3 8 doselorgan, 20 min). Fraction I also exhibited a modest degree of specificity for the striaturn which could be blocked by pretreatment with tetraknazine. The high lipophilicity of & (PoIb for Fraction 1 and I1 = 1723 and 1395. respectively) may contribute to high nonspecific binding in vivo, and result in the low targednontarget ratio observed for this compound.Iodovinyl-TBZ analog a is a poor candidate as a SPECT imaging agent for the vesicular monoamine transporter.